Strategic AI for single cell sequencing & multi-omics advances
As we covered in our recent blog series, we expect advances in single cell sequencing to have an important impact on biomedicine. We predict that new technologies and tools like high-throughput single cell sequencing, spatial technologies, and increased public...
BioLizard joins BioWin
Ghent, 7th February 2024. We are pleased to announce that BioLizard has joined BioWin, the health cluster in Wallonia, Belgium. BioWin is the regional reference for all stakeholders in health, biotech and medtech research, and innovation projects. It currently...
AI in the life sciences: (Un)limited potential?
Artificial Intelligence (AI) is swiftly becoming a cornerstone technology in the early stages of drug discovery and preclinical development. We’re witnessing an increasing number of AI-driven breakthroughs in this field… right? Let’s take a critical look...